The Nasal Microbiome and Its Importance in Disease

Launched by UNIVERSITY OF AARHUS · Sep 21, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the nasal microbiome, which is the collection of bacteria and other microorganisms found in the nose, and how it may relate to conditions like Chronic Rhinosinusitis (CRS), COVID-19, and loss of smell (anosmia). The researchers are looking at different groups of people, including healthy individuals, those with smell problems from COVID-19 or other causes, and patients with CRS. They will collect samples from the nose and throat to analyze the types of microorganisms present and understand how they might influence these conditions.

To participate, individuals aged 65 to 74 who are experiencing these conditions may be eligible. Participants will have their nasal and throat samples collected, and some may undergo a minor surgical procedure to gather additional tissue samples. The goal of this study is to gain insights into how the nasal microbiome and immune system work together, which could help lead to new treatments for chronic nasal issues and improve overall health. It's important for potential participants to know that their involvement will contribute to valuable research that could benefit many people in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Exclusion Criteria:
• • Does not wish to participate in study